Showing 13,941 - 13,960 results of 57,800 for search '(( 2 e decrease ) OR ( 100 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.81s Refine Results
  1. 13941
  2. 13942
  3. 13943
  4. 13944
  5. 13945
  6. 13946

    Effect of BoNT/B and TeTx on VAMP2 Immunofluorescence by Gerardo A. De Blas (262394)

    Published 2013
    “…In contrast, when cells were first allowed to arrive at the intra-acrosomal Ca<sup>2+</sup>-sensitive step and then treated with toxins, BoNT/B caused a significant decrease of the VAMP2 label (asterisks, [J]), whereas TeTx had no effect (S). …”
  7. 13947
  8. 13948

    Increased endothelial cell-cell junction size on stiff matrices is diminished after simvastatin treatment. by Marsha C. Lampi (845609)

    Published 2016
    “…(B) Cell-cell junction size increases with matrix stiffness but decreases with simvastatin (n = 2, 100–200 junctions per condition). …”
  9. 13949

    Table_1_The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.docx by Simon Brackenridge (14281595)

    Published 2024
    “…Therefore, additional studies are required to determine exactly what forms of HLA-E can be recognised by 3D12. In contrast, while staining with 4D12 was also increased when cells were incubated at 27°C, it was decreased when the VL9 peptide was added. …”
  10. 13950

    Table_3_The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.docx by Simon Brackenridge (14281595)

    Published 2024
    “…Therefore, additional studies are required to determine exactly what forms of HLA-E can be recognised by 3D12. In contrast, while staining with 4D12 was also increased when cells were incubated at 27°C, it was decreased when the VL9 peptide was added. …”
  11. 13951

    DataSheet_1_The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.pdf by Simon Brackenridge (14281595)

    Published 2024
    “…Therefore, additional studies are required to determine exactly what forms of HLA-E can be recognised by 3D12. In contrast, while staining with 4D12 was also increased when cells were incubated at 27°C, it was decreased when the VL9 peptide was added. …”
  12. 13952
  13. 13953
  14. 13954
  15. 13955
  16. 13956

    Neurotoxic effect of TTR-A to human cells in a time-course experiment. by Malgorzata Pokrzywa (235155)

    Published 2010
    “…Cell viability was significantly reduced already 18h after exposure to the TTR-A/+ extracts (<i><sup># #</sup> P</i> = 0.005, TTR-A/+ vs. control TTR−/−) and decreased over time in cells exposed to TTR-A/+ and TTR-A/TTR-A but not TTRwt/TTRwt extracts (<i><sup># # #</sup> P</i><0.001, TTR-A/+ and TTR-A/TTR-A vs. control TTR−/− for 24–72h). …”
  17. 13957

    DataSheet_1_Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxi... by Evelien G. E. Hurkmans (9232013)

    Published 2020
    “…Association with methotrexate-induced decreased thrombocyte counts was found for two intronic variants in CYP2B6 {rs4803418 [coef -0.187 (95% CI -0.275 – -0.099); p = 3.04 × 10<sup>-5</sup>] and rs4803419 [coef -0.186 (95% CI -0.278 – -0.093); p = 8.80 × 10<sup>-5</sup>]}. …”
  18. 13958

    E3330 treatment specifically inhibits TNF-α- and FAs-induced IL-8 endogenous gene expression. by Laura Cesaratto (446418)

    Published 2013
    “…</i></b></b> JHH6 cells were pre-treated with 100 µM E3330 or with vehicle (DMSO) as a control, for 4 h prior to treatment with 2000 U/ml TNF-α for 2 h. …”
  19. 13959

    Structure–activity relationship of piperine and its synthetic amide analogs for therapeutic potential to prevent experimentally induced ER stress in vitro by Hammad, Ayat S.

    Published 2017
    “…Pre-treatment of cells with piperine and its cyclohexylamino analog decreased the tunicamycin-induced upregulation of GRP78 and CHOP and cell death. …”
    Get full text
    Get full text
  20. 13960